NDC 50228-464

Pregabalin Extended Release

Pregabalin

Pregabalin Extended Release is a Oral Tablet, Film Coated, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Sciegen Pharmaceuticals, Inc.. The primary component is Pregabalin.

Product ID50228-464_e90bfe09-9adb-03c0-e053-2a95a90a061e
NDC50228-464
Product TypeHuman Prescription Drug
Proprietary NamePregabalin Extended Release
Generic NamePregabalin
Dosage FormTablet, Film Coated, Extended Release
Route of AdministrationORAL
Marketing Start Date2022-09-14
Marketing CategoryANDA /
Application NumberANDA215675
Labeler NameScieGen Pharmaceuticals, INC.
Substance NamePREGABALIN
Active Ingredient Strength330 mg/1
DEA ScheduleCV
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 50228-464-05

500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50228-464-05)
Marketing Start Date2022-09-14
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Pregabalin Extended Release" or generic name "Pregabalin"

NDCBrand NameGeneric Name
0071-1012LyricaPREGABALIN
0071-1013LyricaPREGABALIN
0071-1014LyricaPREGABALIN
0071-1015LyricaPREGABALIN
0071-1016LyricaPREGABALIN
0071-1017LyricaPREGABALIN
0071-1018LyricaPREGABALIN
0071-1019LyricaPREGABALIN
0071-1020LyricaPREGABALIN

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.